id,input,output
0,"This study aimed to evaluate the diagnostic value of the different Complete blood count-derived systemic inflammation indexes, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and neutrophil to lymphocyte × platelet ratio (NLPR) in differential diagnosing the chronic calculus cholecystitis (CCC) and the acute calculus cholecystitis (ACC), as well as determining the severity of ACC.","[{'entity1': 'Systemic inflammation indexes', 'relationship': 'derived from', 'entity2': 'Complete blood count'}, {'entity1': 'NLR', 'relationship': 'associated with', 'entity2': 'differential diagnosing'}, {'entity1': 'PLR', 'relationship': 'associated with', 'entity2': 'differential diagnosing'}, {'entity1': 'SII', 'relationship': 'associated with', 'entity2': 'differential diagnosing'}, {'entity1': 'NLPR', 'relationship': 'associated with', 'entity2': 'differential diagnosing'}, {'entity1': 'CCC', 'relationship': 'differential diagnosing', 'entity2': 'ACC'}, {'entity1': 'ACC', 'relationship': 'differential diagnosing', 'entity2': 'CCC'}, {'entity1': 'ACC', 'relationship': 'determining', 'entity2': 'severity'}]"
1,"105 CCC and 88 ACC patients were enrolled. NLR, PLR, SII, and NLPR were evaluated in both cohorts as well as in different severity levels of ACC. The severity of ACC was determined based on the Tokyo Guidelines. Receiver operating characteristic (ROC) curve and Univariate/multivariate regression analyses were conducted.","[{'entity1': 'CCC patients', 'relationship': 'enrolled', 'entity2': '105'}, {'entity1': 'ACC patients', 'relationship': 'enrolled', 'entity2': '88'}, {'entity1': 'NLR', 'relationship': 'evaluated in', 'entity2': 'both cohorts'}, {'entity1': 'PLR', 'relationship': 'evaluated in', 'entity2': 'both cohorts'}, {'entity1': 'SII', 'relationship': 'evaluated in', 'entity2': 'both cohorts'}, {'entity1': 'NLPR', 'relationship': 'evaluated in', 'entity2': 'both cohorts'}, {'entity1': 'severity levels', 'relationship': 'determined based on', 'entity2': 'Tokyo Guidelines'}, {'entity1': 'ROC curve', 'relationship': 'used for', 'entity2': 'analyses'}, {'entity1': 'Univariate/multivariate regression analyses', 'relationship': 'conducted for', 'entity2': 'evaluations'}]"
2,"The levels of NLR, PLR, SII, and NLPR were significantly higher in the ACC group compared to the CCC group. The optimal cutoff values for NLR, PLR, SII, and NLPR were determined to be 3.89, 144.7, 896.8, and 0.031 respectively. NLR>3.89 demonstrates the highest predictive capability with an AUC of 0.801 and a sensitivity of 72.73%.","[{'entity1': 'NLR levels', 'relationship': 'higher in', 'entity2': 'ACC group'}, {'entity1': 'PLR levels', 'relationship': 'higher in', 'entity2': 'ACC group'}, {'entity1': 'SII levels', 'relationship': 'higher in', 'entity2': 'ACC group'}, {'entity1': 'NLPR levels', 'relationship': 'higher in', 'entity2': 'ACC group'}, {'entity1': 'optimal cutoff values', 'relationship': 'determined for', 'entity2': 'NLR, PLR, SII, NLPR'}, {'entity1': 'NLR', 'relationship': 'demonstrates', 'entity2': 'highest predictive capability'}, {'entity1': 'NLR', 'relationship': 'associated with', 'entity2': 'AUC of 0.801'}, {'entity1': 'NLR', 'relationship': 'associated with', 'entity2': 'sensitivity of 72.73%'}]"
3,"Multivariate analysis showed that NLR>3.89 (OR: 4.169, p = 0.004) and NLPR>0.031 (OR: 4.304, p = 0.005) were dominant in distinguishing ACC from CCC. In ACC patients, the levels of NLR, SII, and NLPR were significantly higher in the Moderate to Severe-degree ACC (MS-ACC) group than in","[{'entity1': 'NLR>3.89', 'relationship': 'dominant in', 'entity2': 'distinguishing ACC from CCC'}, {'entity1': 'NLPR>0.031', 'relationship': 'dominant in', 'entity2': 'distinguishing ACC from CCC'}, {'entity1': 'NLR levels', 'relationship': 'higher in', 'entity2': 'Moderate to Severe-degree ACC group'}, {'entity1': 'SII levels', 'relationship': 'higher in', 'entity2': 'Moderate to Severe-degree ACC group'}, {'entity1': 'NLPR levels', 'relationship': 'higher in', 'entity2': 'Moderate to Severe-degree ACC group'}]"
4,"NLR>3.89 (OR: 4.169, p = 0.004) and NLPR>0.031 (OR: 4.304, p = 0.005) were dominant in distinguishing ACC from CCC. In ACC patients, the levels of NLR, SII, and NLPR were significantly higher in the Moderate to Severe-degree ACC (MS-ACC) group than in Mild-Degree ACC (M-ACC). NLPR > 0.044 exhibited the highest predictive ability with an AUC of 0.778 and a specificity of 91.67%. Multivariate analysis showed that NLR>6.399 (OR: 10.308, p = 0.000) was a possible independent prognostic factor for accessing the severity of ACC.","[{'entity1': 'NLR', 'relationship': 'distinguishing', 'entity2': 'ACC'}, {'entity1': 'NLPR', 'relationship': 'distinguishing', 'entity2': 'ACC'}, {'entity1': 'NLR', 'relationship': 'higher', 'entity2': 'Moderate to Severe-degree ACC'}, {'entity1': 'NLR', 'relationship': 'higher', 'entity2': 'Mild-Degree ACC'}, {'entity1': 'NLPR', 'relationship': 'predictive', 'entity2': 'ACC'}, {'entity1': 'NLR', 'relationship': 'prognostic factor', 'entity2': 'severity of ACC'}]"
5,"Conclusion: Systemic inflammation indexes can be useful in predicting the risk of ACC and MS-ACC. NLR demonstrates the best distinguishing power and sensitivity for distinguishing ACC from CCC, while NLPR shows the best predictive power and specificity for predicting the severity of ACC.","[{'entity1': 'Systemic inflammation indexes', 'relationship': 'predicting', 'entity2': 'risk of ACC'}, {'entity1': 'NLR', 'relationship': 'distinguishing', 'entity2': 'ACC'}, {'entity1': 'NLPR', 'relationship': 'predicting', 'entity2': 'severity of ACC'}]"
6,"Introduction Cholecystitis is a widespread issue characterized by inflammation of the gallbladder, often prompted by blockage of the cystic duct. Calculous cholecystitis (CC) accounts for 95% of cases and can be further classified as chronic calculous cholecystitis (CCC) or acute calculous cholecystitis (ACC) based on the severity of clinical manifestations and the rate of disease progression.","[{'entity1': 'Cholecystitis', 'relationship': 'characterized by', 'entity2': 'inflammation of gallbladder'}, {'entity1': 'CC', 'relationship': 'accounts for', 'entity2': '95% of cases'}, {'entity1': 'CC', 'relationship': 'classified as', 'entity2': 'chronic calculous cholecystitis'}, {'entity1': 'CC', 'relationship': 'classified as', 'entity2': 'acute calculous cholecystitis'}]"
7,ACC is assessed using scoring systems and involves collecting numerous parameters. Accurate diagnosis of different types of cholecystitis is crucial for optimal patient outcomes. Prompt urgent cholecystectomy is recommended for CCC patients. Delayed diagnosis can lead to complications like gallbladder perforation and sepsis.,"[{'entity1': 'ACC', 'relationship': 'assessed using', 'entity2': 'scoring systems'}, {'entity1': 'diagnosis', 'relationship': 'crucial for', 'entity2': 'patient outcomes'}, {'entity1': 'CCC', 'relationship': 'recommended for', 'entity2': 'patients'}, {'entity1': 'delayed diagnosis', 'relationship': 'can lead to', 'entity2': 'complications'}]"
8,White blood cell (WBC) count and leukocyte subtype cells are valuable indicators for predicting the inflammatory process in acute cholecystitis. Elevated WBC count is a primary biomarker for assessing the severity of cholecystitis. Platelets also play a role in inflammation and host defense.,"[{'entity1': 'WBC count', 'relationship': 'valuable indicators for', 'entity2': 'inflammatory process'}, {'entity1': 'WBC count', 'relationship': 'primary biomarker for', 'entity2': 'severity of cholecystitis'}, {'entity1': 'Platelets', 'relationship': 'play a role in', 'entity2': 'inflammation'}]"
9,"Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and neutrophil-to-lymphocyte platelet ratio (NLPR) are potential valuable indicators in assessing the inflammatory process. These indices offer a rapid, accessible, and cost-effective method for differentiating diagnose ACC from CCC and determining the severity of ACC.","[{'entity1': 'NLR', 'relationship': 'potential valuable indicators in', 'entity2': 'inflammatory process'}, {'entity1': 'PLR', 'relationship': 'potential valuable indicators in', 'entity2': 'inflammatory process'}, {'entity1': 'SII', 'relationship': 'potential valuable indicators in', 'entity2': 'inflammatory process'}, {'entity1': 'NLPR', 'relationship': 'potential valuable indicators in', 'entity2': 'inflammatory process'}, {'entity1': 'indices', 'relationship': 'offer', 'entity2': 'method for differentiating diagnose ACC from CCC'}]"
10,"Severe ACC is associated with dysfunction of any one of the following organs/systems: cardiovascular dysfunction, neurological dysfunction, respiratory dysfunction, renal dysfunction, hepatic dysfunction, hematological dysfunction. Mild ACC does not meet the criteria for “Moderate” or “Severe” ACC. Patients with Moderate- and severe-degree inflammations were grouped as the high-degree inflammation group and compared with the mild-degree inflammation group.","[{'entity1': 'Severe ACC', 'relationship': 'associated with', 'entity2': 'organ/system dysfunction'}, {'entity1': 'Mild ACC', 'relationship': 'does not meet', 'entity2': 'criteria'}, {'entity1': 'Patients', 'relationship': 'grouped as', 'entity2': 'high-degree inflammation group'}, {'entity1': 'Patients', 'relationship': 'compared with', 'entity2': 'mild-degree inflammation group'}]"
11,"The criteria for exclusion were established as follows: Patients below 18 years of age or above 90 years of age, complicated with gallbladder polyp or gallbladder carcinoma, complicated with intrahepatic or extrahepatic cholelithiasis, complicated with serious medical diseases such as heart, lung, brain or kidney, complicated with other acute or chronic infections, autoimmune, malignant tumors, or inflammatory diseases, non-calculous cholecystitis.","[{'entity1': 'Patients', 'relationship': 'exclusion criteria', 'entity2': 'age'}, {'entity1': 'Patients', 'relationship': 'exclusion criteria', 'entity2': 'complications'}, {'entity1': 'Patients', 'relationship': 'exclusion criteria', 'entity2': 'medical diseases'}, {'entity1': 'Patients', 'relationship': 'exclusion criteria', 'entity2': 'infections'}, {'entity1': 'Patients', 'relationship': 'exclusion criteria', 'entity2': 'cholecystitis'}]"
12,"Blood specimens were collected under sterile conditions on Day 1 of hospital admission. Blood parameters, such as neutrophil counts, lymphocyte counts, and platelet counts were all recorded. The NLR, PLR, SII, and NLPR were calculated as follows: NLR (neutrophils/lymphocytes ratio), PLR (platelets/lymphocytes ratio), SII ((neutrophils × platelets)/lymphocytes), NLPR (neutrophils/(lymphocytes × platelets ratio).","[{'entity1': 'Blood specimens', 'relationship': 'collected on', 'entity2': 'Day 1 of hospital admission'}, {'entity1': 'Blood parameters', 'relationship': 'recorded', 'entity2': 'neutrophil counts'}, {'entity1': 'Blood parameters', 'relationship': 'recorded', 'entity2': 'lymphocyte counts'}, {'entity1': 'Blood parameters', 'relationship': 'recorded', 'entity2': 'platelet counts'}, {'entity1': 'NLR', 'relationship': 'calculated as', 'entity2': 'neutrophils/lymphocytes ratio'}, {'entity1': 'PLR', 'relationship': 'calculated as', 'entity2': 'platelets/lymphocytes ratio'}, {'entity1': 'SII', 'relationship': 'calculated as', 'entity2': '(neutrophils × platelets)/lymphocytes'}, {'entity1': 'NLPR', 'relationship': 'calculated as', 'entity2': 'neutrophils/(lymphocytes × platelets ratio)'}]"
13,"Peripheral blood was collected into pre-coagulation tubes and centrifuged for the serum. The serum was then analyzed for various biochemical parameters including ALT, AST, GGT, ALP, TC, TG, HDL-C, LDL-C, Apo AI, Apo B, Lp (a), CREA using the Beckman Coulter AU5800 Automatic.","[{'entity1': 'Peripheral blood', 'relationship': 'collected into', 'entity2': 'pre-coagulation tubes'}, {'entity1': 'Serum', 'relationship': 'analyzed for', 'entity2': 'biochemical parameters'}, {'entity1': 'Serum', 'relationship': 'analyzed using', 'entity2': 'Beckman Coulter AU5800 Automatic'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'ALT'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'AST'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'GGT'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'ALP'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'TC'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'TG'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'HDL-C'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'LDL-C'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'Apo AI'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'Apo B'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'Lp (a)'}, {'entity1': 'Biochemical parameters', 'relationship': 'include', 'entity2': 'CREA'}]"
14,"A total of 105 patients with CCC (36 male, 69 female) with a median age of 52 years (range: 18–80) and 88 patients with ACC (51 male, 37 female) with a median age of 56.5 years (range: 23–88) were included in this study based on specific inclusion and exclusion criteria.","[{'entity1': 'CCC patients', 'relationship': 'included', 'entity2': 'study'}, {'entity1': 'ACC patients', 'relationship': 'included', 'entity2': 'study'}]"
15,"The laboratory findings indicated that patients with ACC had significantly higher levels of liver function enzymes such as AST, ALP, and GGT compared to CCC patients, with GGT showing the most notable increase.","[{'entity1': 'ACC patients', 'relationship': 'higher levels', 'entity2': 'liver function enzymes'}, {'entity1': 'GGT', 'relationship': 'increase', 'entity2': 'ACC patients'}]"
16,"Conversely, ACC patients exhibited decreased concentrations of TC, TG, LDL-C, Apo AI, and Apo B in comparison to CCC patients.","[{'entity1': 'ACC patients', 'relationship': 'decreased concentrations', 'entity2': 'serum parameters'}, {'entity1': 'CCC patients', 'relationship': 'comparison', 'entity2': 'ACC patients'}]"
17,"Furthermore, ACC patients had higher White blood cell and neutrophil counts but lower relative lymphocyte counts compared to CCC patients.","[{'entity1': 'ACC patients', 'relationship': 'higher counts', 'entity2': 'White blood cells'}, {'entity1': 'ACC patients', 'relationship': 'higher counts', 'entity2': 'neutrophils'}, {'entity1': 'ACC patients', 'relationship': 'lower counts', 'entity2': 'lymphocytes'}, {'entity1': 'CCC patients', 'relationship': 'comparison', 'entity2': 'ACC patients'}]"
18,"Comparison of Important Laboratory Parameters Between CCC and ACC. Age, years, Female, n (%), Hospitalization, Day, Laboratory test ALT, U/L, AST, U/L, ALP, U/L, GGT, U/L, TC, nmol/L, TG, nmol/L, HDL-C, nmol/L, LDL-C, nmol/L, Apo AI, g/L, Apo B, g/L, Lp (a), mg/L, CREA, μmol/L, WBC, 109/L, LYM, 109/L, NEUT, 109/L, PLT, 109/L, INR.","[{'entity1': 'CCC', 'relationship': 'comparison', 'entity2': 'ACC'}, {'entity1': 'ALT', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'AST', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'ALP', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'GGT', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'TC', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'TG', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'HDL-C', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'LDL-C', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'Apo AI', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'Apo B', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'Lp (a)', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'CREA', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'WBC', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'LYM', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'NEUT', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'PLT', 'relationship': 'laboratory test', 'entity2': 'CCC'}, {'entity1': 'INR', 'relationship': 'laboratory test', 'entity2': 'CCC'}]"
19,"Among the patients with ACC, there were 36 cases of mild-degree inflammation (M-ACC) and 52 cases of moderate- and severe-degree inflammation (MS-ACC). Severe ACC was present in only three patients, with one case involving hepatic dysfunction, another with respiratory complications, and the third demonstrating cardiological dysfunction. The average age of patients with M-ACC was 50.4 years, while for the MS-ACC group, it was 59.5 years. Apo AI levels were notably lower in MS-ACC patients compared to those with M-ACC.","[{'entity1': 'Mild-degree inflammation', 'relationship': 'present in', 'entity2': 'ACC'}, {'entity1': 'Moderate-degree inflammation', 'relationship': 'present in', 'entity2': 'ACC'}, {'entity1': 'Severe ACC', 'relationship': 'present in', 'entity2': 'patients'}, {'entity1': 'Severe ACC', 'relationship': 'involving', 'entity2': 'hepatic dysfunction'}, {'entity1': 'Severe ACC', 'relationship': 'involving', 'entity2': 'respiratory complications'}, {'entity1': 'Severe ACC', 'relationship': 'demonstrating', 'entity2': 'cardiological dysfunction'}, {'entity1': 'M-ACC patients', 'relationship': 'average age', 'entity2': '50.4 years'}, {'entity1': 'MS-ACC group', 'relationship': 'average age', 'entity2': '59.5 years'}, {'entity1': 'Apo AI levels', 'relationship': 'lower in', 'entity2': 'MS-ACC patients'}]"
20,"Analysis of blood parameters revealed a significant increase in WBC and neutrophil counts in MS-ACC patients compared to M-ACC patients, whereas the lymphocyte count was significantly lower in the MS-ACC group than in the M-ACC group.","[{'entity1': 'WBC', 'relationship': 'increase in', 'entity2': 'MS-ACC patients'}, {'entity1': 'neutrophil counts', 'relationship': 'increase in', 'entity2': 'MS-ACC patients'}, {'entity1': 'lymphocyte count', 'relationship': 'lower in', 'entity2': 'MS-ACC group'}]"
21,"The NLR value was markedly higher in ACC patients [6.444 (3.199–11.446)] compared to the CCC group [1.971 (1.519–3.301), P <0.001]. Also, there was a notable rise in the PLR [169.121 (125.75–246.336) and 127.253 (98.612–174.706); respectively, P <0.001], SII [1470.792 (689.186–2758.316)) and 440.228 (315.366–872.194); respectively, P <0.001] and NLPR [0.030 (0.014–0.058) and 0.008 (0.006–0.015); respectively, P < 0.001], in ACC patients compared to the CCC group.","[{'entity1': 'NLR value', 'relationship': 'higher in', 'entity2': 'ACC patients'}, {'entity1': 'PLR', 'relationship': 'rise in', 'entity2': 'ACC patients'}, {'entity1': 'SII', 'relationship': 'rise in', 'entity2': 'ACC patients'}, {'entity1': 'NLPR', 'relationship': 'rise in', 'entity2': 'ACC patients'}]"
22,"The demographic data and laboratory results of the ACC patients were stratified according to the severity grade. The variables included age, gender, hospitalization days, ALT, AST, ALP, GGT, TC, TG, HDL-C, LDL-C, Apo AI, Apo B, Lp (a), CREA, WBC, LYM, NEUT, PLT, and INR.","[{'entity1': 'ACC patients', 'relationship': 'stratified', 'entity2': 'severity grade'}, {'entity1': 'Demographic data', 'relationship': 'included', 'entity2': 'age, gender, hospitalization days'}, {'entity1': 'Laboratory results', 'relationship': 'included', 'entity2': 'ALT, AST, ALP, GGT, TC, TG, HDL-C, LDL-C, Apo AI, Apo B, Lp (a), CREA, WBC, LYM, NEUT, PLT, INR'}]"
23,"The mean and standard deviation, median [25th–75th percentile], or number (percentage) were used to present the data. The comparison between the mild ACC group (M-ACC) and the moderate to severe ACC group (MS-ACC) was conducted.","[{'entity1': 'Data', 'relationship': 'presented as', 'entity2': 'mean ± standard deviation, median [25th–75th percentile], or number (percentage)'}, {'entity1': 'Comparison', 'relationship': 'conducted between', 'entity2': 'M-ACC and MS-ACC group'}]"
24,"Comparison for Assessing the Discriminative Ability of Each Inflammation Indexes to Distinguishing AAC from CCC Patients. Receiver operating characteristic (ROC) curve analysis was conducted to assess the discriminative ability of various inflammation indices in differentiating between AAC and CCC patients. The NLR demonstrated a sensitivity of 72.73%, a specificity of 80.95%, and an AUC of 0.801 at a cut-off of 3.89 (P < 0.001). The PLR showed a sensitivity of 68.18%, a specificity of 61.9%, and an AUC of 0.662 at a cut-off of 144.7. Additionally, the SII exhibited a sensitivity of 69.32%, a specificity of 76.19%, and an AUC of 0.777 at a cut-off of 896.8 (P < 0.001), while the NLPR had a sensitivity of 63.64%, a specificity of 86.67%, and an AUC of 0.776 at a cut-off of 0.031 (P < 0.001). Overall, the NLR displayed the highest AUC and sensitivity among the indexes assessed.","[{'entity1': 'NLR', 'relationship': 'sensitivity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'NLR', 'relationship': 'specificity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'NLR', 'relationship': 'AUC', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'PLR', 'relationship': 'sensitivity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'PLR', 'relationship': 'specificity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'PLR', 'relationship': 'AUC', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'SII', 'relationship': 'sensitivity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'SII', 'relationship': 'specificity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'SII', 'relationship': 'AUC', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'NLPR', 'relationship': 'sensitivity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'NLPR', 'relationship': 'specificity', 'entity2': 'AAC vs CCC patients'}, {'entity1': 'NLPR', 'relationship': 'AUC', 'entity2': 'AAC vs CCC patients'}]"
25,"Comparison for Assessing the Discriminative Ability of Each Inflammation Indexes to Predict the Severity of ACC. In addition, ROC Curve Analysis demonstrated that NLR, SII, and NLPR might be acceptable in the differentiation of M-ACC and MS-ACC patients. The areas under the curve (AUC) for NLR, SII, and NLPR were 0.760, 0.723, and 0.778, respectively. The optimal cut-off values were identified as 6.399, 1261, and 0.044 for NLR, SII, and NLPR. Sensitivities for NLR, SII, and NLPR were found to be 71.15%, 72.22%, and 61.54%, while specificities were 80.56%, 73.08%, and","[{'entity1': 'NLR', 'relationship': 'differentiation', 'entity2': 'M-ACC vs MS-ACC patients'}, {'entity1': 'NLR', 'relationship': 'AUC', 'entity2': 'M-ACC vs MS-ACC patients'}, {'entity1': 'SII', 'relationship': 'differentiation', 'entity2': 'M-ACC vs MS-ACC patients'}, {'entity1': 'SII', 'relationship': 'AUC', 'entity2': 'M-ACC vs MS-ACC patients'}, {'entity1': 'NLPR', 'relationship': 'differentiation', 'entity2': 'M-ACC vs MS-ACC patients'}, {'entity1': 'NLPR', 'relationship': 'AUC', 'entity2': 'M-ACC vs MS-ACC patients'}]"
26,"Abbreviations: ACC, acute calculous cholecystitis; CCC, chronic calculous cholecystitis.","[{'entity1': 'ACC', 'relationship': 'abbreviation', 'entity2': 'acute calculous cholecystitis'}, {'entity1': 'CCC', 'relationship': 'abbreviation', 'entity2': 'chronic calculous cholecystitis'}]"
27,"NLR, SII, and NLPR were found to be 71.15%, 72.22%, and 61.54%, while specificities were 80.56%, 73.08%, and 91.67%. Nonetheless, the diagnostic potential of PLR was not supported by the ROC analysis, as it did not reach a significant level (P = 0.309).","[{'entity1': 'NLR', 'relationship': 'diagnostic potential', 'entity2': 'not supported'}, {'entity1': 'PLR', 'relationship': 'diagnostic potential', 'entity2': 'not supported'}, {'entity1': 'SII', 'relationship': 'diagnostic potential', 'entity2': 'supported'}, {'entity1': 'NLPR', 'relationship': 'diagnostic potential', 'entity2': 'supported'}]"
28,Univariate and Multivariate Logistic Regression Analysis Univariate and multivariable binary logistic analyses were conducted to evaluate the clinical significance of Inflammation Indices as biomarkers in distinguishing between ACC and CCC patients.,"[{'entity1': 'Univariate', 'relationship': 'analysis', 'entity2': 'Inflammation Indices'}, {'entity1': 'Multivariate', 'relationship': 'analysis', 'entity2': 'Inflammation Indices'}, {'entity1': 'Inflammation Indices', 'relationship': 'biomarkers', 'entity2': 'distinguishing'}, {'entity1': 'Inflammation Indices', 'relationship': 'clinical significance', 'entity2': 'ACC and CCC patients'}]"
29,"Variables that demonstrated a P-value of <0.1 in the univariate analysis were subsequently included in the multivariable binary logistic analysis, encompassing TC, TG, LDL-C, Apo AI, Apo B, sex, NLR, PLR, SII, and NLPR.","[{'entity1': 'Variables', 'relationship': 'included in', 'entity2': 'multivariable binary logistic analysis'}, {'entity1': 'Variables', 'relationship': 'demonstrated', 'entity2': 'P-value'}, {'entity1': 'Variables', 'relationship': 'encompassing', 'entity2': 'TC, TG, LDL-C, Apo AI, Apo B, sex, NLR, PLR, SII, and NLPR'}]"
30,Multiple logistic regression models further confirmed that age and NLR were significant independent predictive factors of severity in ACC patients.,"[{'entity1': 'age', 'relationship': 'predictive factors', 'entity2': 'severity in ACC patients'}, {'entity1': 'NLR', 'relationship': 'predictive factors', 'entity2': 'severity in ACC patients'}]"
31,"We indicated that the cut-off values for NLR, PLR, SII, and NLPR in differentiating between ACC and CCC patients were 3.89, 144.7, 896.8, and 0.031 (respectively), while in distinguishing between M-ACC and MS-ACC patients, the cut-off value for NLR, SII, and NLPR was much higher (6.39, 1261 and 0.044).","[{'entity1': 'NLR', 'relationship': 'differentiating', 'entity2': 'ACC and CCC patients'}, {'entity1': 'PLR', 'relationship': 'differentiating', 'entity2': 'ACC and CCC patients'}, {'entity1': 'SII', 'relationship': 'differentiating', 'entity2': 'ACC and CCC patients'}, {'entity1': 'NLPR', 'relationship': 'differentiating', 'entity2': 'ACC and CCC patients'}, {'entity1': 'NLR', 'relationship': 'distinguishing', 'entity2': 'M-ACC and MS-ACC patients'}, {'entity1': 'SII', 'relationship': 'distinguishing', 'entity2': 'M-ACC and MS-ACC patients'}, {'entity1': 'NLPR', 'relationship': 'distinguishing', 'entity2': 'M-ACC and MS-ACC patients'}]"
32,Table 3 ROC Curve Analysis for Different Inflammation Indices for Determining the Cut-off Between CCC and AAC Patients,"[{'entity1': 'ROC Curve Analysis', 'relationship': 'determining', 'entity2': 'Cut-off Between CCC and AAC Patients'}]"
33,Table 4 Comparison of ROC Curve Analysis of Different Inflammation Indices in Predicting the Severity of Cholecystitis,"[{'entity1': 'ROC Curve Analysis', 'relationship': 'predicting', 'entity2': 'Severity of Cholecystitis'}]"
34,Table 5 Univariate and Multivariate Logistic Regression Analysis for the Factors Distinguishing ACC from CCC Patients,"[{'entity1': 'Univariate Regression', 'relationship': 'distinguishing', 'entity2': 'ACC from CCC Patients'}, {'entity1': 'Multivariate Regression', 'relationship': 'distinguishing', 'entity2': 'ACC from CCC Patients'}]"
35,"Considering the four inflammatory parameters associated with CC, NLR has been extensively studied and is considered a reliable marker for prognosticating diseases involving inflammatory and infective processes. Previous literature has shown that NLR is significantly higher in acute cholecystitis compared to healthy controls, ranging from 5.29–12.16 compared to 1.73–2.98. However, there have been limited studies focusing on the predictive value of NLR in differentiating acute and chronic cholecystitis. Our study supports previous findings that NLR levels were significantly higher in acute cholecystitis compared to chronic cholecystitis. We found that an NLR value above 3.89 was significant in the ACC group compared to the CCC group, and above 6.399 was significant in the MS-ACC patients. The binary logistic regression analysis revealed that an NLR exceeding the cutoff value independently predicts ACC and its severity. The increase in NLR cutoff values corresponds to higher estimates of inflammatory severity, which can be attributed to an imbalance in the inflammatory response with elevated neutrophil levels. This imbalance may result in the exhaustion of the immune system and a decrease in lymphocyte counts, subsequently triggering an aggressive inflammatory reaction through the activation of the innate immune","[{'entity1': 'NLR', 'relationship': 'marker', 'entity2': 'prognosticating diseases'}, {'entity1': 'NLR', 'relationship': 'higher', 'entity2': 'acute cholecystitis'}, {'entity1': 'NLR', 'relationship': 'predicts', 'entity2': 'ACC'}, {'entity1': 'NLR', 'relationship': 'imbalance', 'entity2': 'inflammatory response'}, {'entity1': 'neutrophil levels', 'relationship': 'elevated', 'entity2': 'inflammatory response'}, {'entity1': 'immune system', 'relationship': 'exhaustion', 'entity2': 'imbalance'}]"
36,"Odds Ratio (OR) 95% CI P value Odds Ratio (OR) 95% CI P value Lower Upper Lower Upper TC(<4.39) TG(<1.06) 0.478 0.542 0.267 0.855 0.013* 0.304 0.965 0.038* LDL-C(<2.28) 0.478 0.267 0.855 0.013* Apo AI (<1.13) 0.318 0.175 0.579 0.000* 2.284 1.064 4.900 0.031 Apo B(<0.7) 0.520 0.291 0.928 0.027* NLR(>3.89) 11.333 5.763 22.287 0.000* 4.169 1.583 10.976 0.004 PLR(>144.7) 3.482 1.917 6.326 0.000* SII(>896.8) 7.230 3.820 13.682 0.000* NLPR(>0.031) 11.375 5.588 23.155 0.000* 4.304 1.556 11.908 0.005 Age (>57) Sex (%) 1.476 2.642 0.830 2.627 0.18 1.473 4.739 0.001* 2.369 1.115 5.035 0.025 Notes: *Parameters with P value <0.10 were included in multivariate analysis. The level of significance was accepted at P < 0.05. Abbreviations: TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; Apo AI, apolipoprotein AI; Apo B, apolipoprotein B; NLR, the neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; SII, systemic inflammation index; NLPR, neutrophil to lymphocyte × platelet ratio; CI, confidence interval.","[{'entity1': 'NLR', 'relationship': 'ratio', 'entity2': 'neutrophil to lymphocyte'}, {'entity1': 'PLR', 'relationship': 'ratio', 'entity2': 'platelet to lymphocyte'}, {'entity1': 'SII', 'relationship': 'index', 'entity2': 'systemic inflammation'}, {'entity1': 'NLPR', 'relationship': 'ratio', 'entity2': 'neutrophil to lymphocyte × platelet'}, {'entity1': 'Age', 'relationship': 'above', 'entity2': '57'}, {'entity1': 'Sex', 'relationship': 'percentage', 'entity2': '2.627'}]"
